GlassScriptPhysician profile
Ryan P Richard
NPI 1649538471
$2,673.58
in general payments reported to CMS, 2019-2025
29 companies · $1,112 in 2025
The $1,112 reported for 2025 was more than what 79% of Critical Care Medicine (Internal Medicine) providers received nationally (typical 2025 total: $189).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $10.86 · 2020: $242 · 2021: $244 · 2022: $67.74 · 2023: $513 · 2024: $484 · 2025: $1,112.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,103 · Travel and Lodging: $6.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,103.05 |
| Travel and Lodging | $6.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $411.40 | 2024-2025 | |
| Merck Sharp & Dohme LLC | $250.77 | 2020-2025 | Winrevair, Keytruda |
| Astrazeneca Pharmaceuticals LP | $236.17 | 2022-2025 | Tezspire, Fasenra, Breztri |
| Baxter Healthcare | $195.49 | 2023-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| Actelion Pharmaceuticals US, INC. | $162.90 | 2023-2025 | Uptravi, Opsumit, Opsynvi |
| United Therapeutics Corporation | $144.36 | 2022-2025 | Tyvaso, Tyvaso |
| Alexion Pharmaceuticals, INC. | $121.83 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $99.21 | 2020-2025 | Ofev, Jascayd |
| Intuitive Surgical, INC. | $90.04 | 2023-2024 | Da Vinci Surgical System |
| Glaxosmithkline, LLC. | $85.71 | 2022-2025 | Trelegy Ellipta |
| Viatris Specialty LLC | $83.89 | 2025 | Yupelri |
| Allergan, INC. | $81.99 | 2019-2020 | |
| Ethicon INC. | $76.11 | 2021 | |
| Abiomed | $67.16 | 2025 | |
| Insmed, INC. | $66.46 | 2023-2025 | Arikayce, Brinsupri |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ani Pharmaceuticals, INC. | $60.64 | 2025 | Purified Cortrophin Gel |
| Mylan Specialty L.P. | $59.91 | 2023-2024 | Yupelri |
| Abbvie INC. | $56.83 | 2021-2025 | |
| La Jolla Pharmaceutical Company | $44.08 | 2025 | Giapreza, Zevtera |
| Philips North America LLC | $40.82 | 2024 | (Ak6) Vest Therapy |
| Tactile Systems Technology INC | $38.82 | 2023 | Entre Plus, Flexitouch Plus |
| Grifols USA, LLC | $37.43 | 2024 | Prolastin-C Liquid |
| Paratek Pharmaceuticals, INC. | $36.45 | 2020-2024 | Nuzyra |
| Bayer Healthcare Pharmaceuticals INC. | $29.01 | 2021-2023 | |
| Verona Pharma, INC. | $25.82 | 2025 | Ohtuvayre |
| Astellas Pharma US INC | $19.30 | 2021 | |
| Pfizer INC. | $18.33 | 2025 | |
| Novartis Pharmaceuticals Corporation | $17.86 | 2023 | |
| Regeneron Healthcare Solutions, INC. | $14.79 | 2025 | Dupixent |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Richard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.